Solanbridge Group Inc Announces Acquisition of Tasty Greenz and 500 Million Share Reduction - Hawaii News Now - KGMB and KHNL

Solanbridge Group Inc Announces Acquisition of Tasty Greenz and 500 Million Share Reduction

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Solanbridge Group Inc

HOUSTON, May 8, 2014 /PRNewswire/ -- Solanbridge Group Inc (OTC: SLNX) is pleased to announce the closing of the acquisition of Tasty Greenz, LLC of Denver, Colorado, a health product producer whose products are derived from naturally occurring cannabinoids and, in particular, cannabidiol (CBD). CBD is related to tetrahydrocannabinol (the psychoactive constituent of the cannabis plant).  CBD possesses no psychoactive properties and therefore is a ready for market marijuana based ingredient.  Dr. Mark T. Cullen, chairman of the Scientific Advisory Board of SLNX stated, "We are pleased to announce that Tasty Greenz has agreed to join Solanbridge. We are looking forward to working jointly with Tasty Greenz to further develop the medical products that they have designed to utilize cannabidiol ("CBD"), one of the many active ingredients derived from marijuana."

Cullen is a Yale University-trained doctor and medical director, who had academic appointments at Yale University and University of Florida.  Dr. Cullen has done collaborative work with the World Health Organization (WHO), the Center for Disease Control (CDC) and the National Institute of Health (NIH).  He is an entrepreneur who has developed start-up companies and has also worked as the CEO of multiple companies both public and private.  He is an inventor who has created ultrasound desulfurization and heavy oil upgrade technology.  His work has taken him throughout the world including Saudi Arabia, UAE, India, and South America.

Charles R. Shirley, Chairman of the Board and Managing Director of Solanbridge, stated that on May 7, 2014, due to the commitment of Solanbridge to the medical marijuana industry, the Company has cancelled and retired another 500 million common stock shares of SLNX. Those shares will be returned to the Company's Treasury immediately. Concurrent with the announcement of the Company's total share reduction, the Company emphasized that the long-term goal of the Company is to reduce the number of common stock shares by another 500 billion common stock shares over the next month-for a total cancellation and retirement of 1.5 billion common stock shares overall.

Solanbridge is also encouraged by the changing public opinion landscape in certain U.S. jurisdictions and the potential for legislative changes toward medical marijuana legalization in Florida and Maryland, two jurisdictions where Solanbridge has a physical presence.

The Company continues to pursue a commercial grower's license in Province of Nova Scotia.  Plans have been developed to hire a full-time staff member to administer the application process, acquire a building, equip the building with a state-of-the-art security system, and build out all aspects of a commercial medical marijuana grower's production facility. The MOU signed by the Company on March 29, 2014 has been extended for fourteen (14) more business days.

About Solanbridge Group Inc

Solanbridge Group Inc is based in Spring, Texas and is a diversified holding company looking to expand into the medical marijuana industry by developing a commercial grower's license in the Province of Nova Scotia, Canada and developing CBD-infused products in Colorado, Nevada, and California through its subsidiary Tasty Greenz LLC. Solanbridge's other subsidiary, David's Steak and Seafood, in Melbourne Beach, Florida, is a classic, upscale steak house, which presents polished dining in an atmosphere of timeless elegance, offering guests the finest cuts of choice USDA meats, fresh seafood and much more.

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

©2012 PR Newswire. All Rights Reserved.